SINUVA was proven to shrink nasal polyps and reduced symptoms of nasal obstruction and congestion for up to 90 days because it is placed directly among the nasal polyps. It provides targeted, continuous symptom relief, with a low rate of side effects.
In clinical trials:
The most common side effects were asthma, headache, and nosebleed. The most common side effects observed (in more than 1% of subjects and that occurred more frequently in patients who received SINUVA compared to patients who were given daily steroid nasal spray) in clinical studies were bronchitis, upper respiratory or middle ear infection, headache, lightheadedness, asthma, and nosebleed.